1173977-35-9Relevant articles and documents
Discovery and optimization of N-(3-(1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c] pyridin-4-yloxy)phenyl)benzenesulfonamides as novel GPR119 agonists
Yu, Ming,Zhang, Jian,Wang, Yingcai,Zhu, Jiang,Kayser, Frank,Medina, Julio C.,Siegler, Karen,Conn, Marion,Shan, Bei,Grillo, Mark P.,Coward, Peter,Liu, Jiwen
, p. 156 - 160 (2014)
The discovery and optimization of novel N-(3-(1,3-dioxo-2,3-dihydro-1H- pyrrolo[3,4-c]pyridin-4-yloxy)phenyl)benzenesulfonamide GPR119 agonists is described. Modification of the pyridylphthalimide motif of the molecule with R1 =-Me and R2 =-iPr substituents, incorporated with a 6-fluoro substitution on the central phenyl ring offered a potent and metabolically stable tool compound 22.
BIS-ARYL COMPOUNDS FOR USE AS MEDICAMENTS
-
Page/Page column 101, (2009/12/02)
There is provided compounds of formula I, wherein ring A, D1, D2a, D2b, D3, L1, Y1, L3 and Y3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C4 synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.